BRNS
Barinthus Biotherapeutics Plc. ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.63
+0.03 ▲ +4.83%
🌙 3월 13일 6:01 PM ET (한국 3/14 07:01)
$0.63
+0.00 +0.13%
| Index | - | P/E | - | EPS (ttm) | -1.89 | Insider Own | 3.48% | Shs Outstand | 0.04B | Perf Week | 4.31% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.04B | Perf Month | -4.84% |
| Enterprise Value | -0.04B | PEG | - | EPS next Q | -0.36 | Inst Own | 15.88% | Short Float | 0.02% | Perf Quarter | -10.65% |
| Income | -0.08B | P/S | - | EPS this Y | 13.41% | Inst Trans | -4.62% | Short Ratio | 0.15 | Perf Half Y | -44.34% |
| Sales | 0.00B | P/B | 0.3 | EPS next 5Y | - | ROA | -50.98% | Short Interest | 0.01M | Perf YTD | -10.16% |
| Book/sh | 2.07 | P/C | 0.34 | EPS past 3/5Y | -4.32% - | ROE | -62.3% | 52W High | -78.46% ($2.92) | Perf Year | -40.66% |
| Cash/sh | 1.85 | P/FCF | - | Sales past 3/5Y | 282.32% 16.85% | ROIC | -80.76% | 52W Low | 12.32% ($0.56) | Perf 3Y | -74.12% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -26.31% | Gross Margin | - | Volatility(W/M) | 7.67% 9.97% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 8.04 | EPS Q/Q | -71.15% | Profit Margin | - | RSI (14) | 50.72 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 8.04 | Sales Q/Q | -100% | SMA20 | 4.67% ($0.6) | Beta | -0.63 | Target Price | $4 |
| Payout | - | Debt/Eq | 0.14 | Earnings | 3000000 | SMA50 | -6.69% ($0.68) | Rel Volume | 0.1 | Prev Close | $0.6 |
| Employees | 105 | LT Debt/Eq | 0.11 | EPS/Sales Surpr. | 21.74% - | SMA200 | -36.71% ($1) | Avg Volume(3M) | 0.06M | Price | $0.63 |
| IPO | 2021/4/30 | Option/Short | No/Yes | Trades | 44 | Volume | 5,365 | Change | 4.83% |
뉴스 로딩 중...